Pfizer is the biggest drug firm in the world, with 100,000 employees, $51 billion in annual sales and a research budget of more than $7 billion. But even though the company has three dozen drugs in late-stage testing, investors have been laser-focused on a single experimental medicine: torcetrapib, a drug to raise “good cholesterol.”>>> Discuss This Story
